SLC7A11 and cancer: The crosstalk between SLC7A11 and other 32 malignancies with pan-cancer analysis revealed that SLC7A11 showed positive correlations with multiple ICs in most cancer types, but it also predicted a high risk of adverse outcomes in several cancers.